When should patients with metastatic melanoma be referred for treatment at an academic center?
With novel therapies quickly evolving, it's becoming more difficult to discern the proper sequence of therapies and the point at which a clinical trial is the best option.
Answer from: Medical Oncologist at Academic Institution
In order to move the field forward and advance care for metastatic melanoma patients, all patients with a good performance status should be considered for clinical trials. That said, trials need to be carefully designed and appropriate pre-clinical studies should be done as there now are quite ...